The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

This best practice guide is written with the aim of providing an overview of current hybrid
closed‐loop (HCL) systems in use within the United Kingdom's (UK) National Health Service …

Abstract Background Glycaemic control of Type 1 Diabetes Mellitus (T1DM) remains a
challenge due to hypoglycaemic episodes and the burden of insulin self-management …

Objective. While automated insulin delivery (AID) systems aim to improve glycemic
outcomes, the opportunity to improve psychosocial outcomes is also of critical importance for …

Aim To explore the lived experience of older adults with type 1 diabetes using closed‐loop
automated insulin delivery, an area previously receiving minimal attention. Methods Semi …

Background Conclusive evidence on the benefits of automated insulin delivery (AID)
systems on person-reported outcomes (PROs) is missing. Methods In this systematic review …

Introduction Over the last five years, closed-loop insulin delivery systems have transitioned
from research-only to real-life use. A number of systems have been commercialized and are …

Aim The purpose of this study was to develop a questionnaire to examine the future
acceptance of Automatic insulin delivery systems (AIDs), their perceived usefulness, ease of …

Background Insulin pump therapy (IPT) improves glucose control in people with type 1
diabetes (T1D) compared with multiple daily injections (MDI). However, their size, the …